Pharmaceutical Industry
The Trump Administration’s US Drug Pricing Proposal – What will happen next?
12 June 2025
This is the second in our series of Insights considering the implications of President Trump’s Executive Order on ‘Most Favoured Nation’ drug pricing. We know that…
Bold politics – what about the economics?: An overview of President Trump’s ‘Most Favoured Nation’ Executive Order
2 June 2025
This is the first in a series of OHE Insights on the history, implications and possible impact of President Trump’s Executive Order on a “Most Favoured Nation” (MFN) pricing model for pharmaceuticals.
New free educational program launched – Explaining the U.S. Inflation Reduction Act
9 May 2023
We have launched a free online explainer to the U.S. Inflation Reduction Act. It makes essential viewing for anyone wanting a sound knowledge of the technical detail of the Act and how it relates to pharmaceutical payment and coverage.
Fishing for Innovative Drugs with the ODRS: Potential Benefits and Challenges
6 February 2023
During an engaging discussion of Professor Aidan Hollis’ prizewinning proposal with Professor Adrian Towse a range of potential benefits and remaining questions were explored.
The UK Biotech Sector and Brexit: Past Performance and Future Prospects
1 April 2018
This seminar briefing examines (1) why the UK has not produced large biotech firms that develop drugs, similar to those in the United States (US), (2)…
Biotechnology and the Economics of Discovery in the Pharmaceutical Industry
1 October 1998
This paper examines the economic aspects of the forces driving the emergence of biotechnology firms, and the implications of this for the organisation of research and…
Industrial Policy and the Pharmaceutical Industry
1 January 1995
This book contains the proceedings o f a conference held by the Office of Health Economics in June 1994. The papers, by a number of distinguished…
Innovative Chemical Extensions: The Economic Basis of Pharmaceutical Progress
1 December 1988
This is an important paper based on original economic analyses of the new entrants to various pharmaceutical sub-markets. To use a sporting analogy, it indicates that…
Pharmaceuticals in seven nations
1 May 1985
Great Britain at the suggestion of and in close collaboration with Medizinisch Pharmazeutische Studiengesellschaft (MPS) in the Federal Republic of Germany, OHE is funded entirely by…